0002100119-26-000006.txt : 20260427 0002100119-26-000006.hdr.sgml : 20260427 20260427170638 ACCESSION NUMBER: 0002100119-26-000006 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20260427 DATE AS OF CHANGE: 20260427 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Indivior Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001625297 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 412520873 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-94167 FILM NUMBER: 26901921 BUSINESS ADDRESS: STREET 1: 10710 MIDLOTHIAN TURNPIKE STREET 2: SUITE 125 CITY: NORTH CHESTERFIELD STATE: VA ZIP: 23235 BUSINESS PHONE: 804-379-1090 MAIL ADDRESS: STREET 1: 10710 MIDLOTHIAN TURNPIKE STREET 2: SUITE 125 CITY: NORTH CHESTERFIELD STATE: VA ZIP: 23235 FORMER COMPANY: FORMER CONFORMED NAME: INDIVIOR PLC DATE OF NAME CHANGE: 20141114 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: VANGUARD CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0002100119 ORGANIZATION NAME: EIN: 392877419 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 LEGAL ENTITY IDENTIFIER: 529900ZEWTRLEJ6XE960 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: 100 VANGUARD BLVD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-669-6148 MAIL ADDRESS: STREET 1: 100 VANGUARD BLVD CITY: MALVERN STATE: PA ZIP: 19355 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0002100119 XXXXXXXX LIVE Common Stock 03/31/2026 0001625297 Indivior Pharmaceuticals Inc 45579U109 10710 MIDLOTHIAN TURNPIKE SUITE 125 NORTH CHESTERFIELD VA 23235 Rule 13d-1(b) Vanguard Capital Management PA 937144 0 6523720 0 6523720 5.35 IA In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Capital Management LLC and the following affiliates of Vanguard Capital Management LLC or business divisions of such affiliates: Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC and Vanguard Investments Australia Ltd. This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Capital Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power. This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Capital Management LLC, or business divisions of such subsidiaries, whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release. Indivior Pharmaceuticals Inc 10710 MIDLOTHIAN TURNPIKE, SUITE 125, NORTH CHESTERFIELD, VA, 23235 Vanguard Capital Management 100 Vanguard Blvd,, Malvern, PA, 19355 PA N IA 6523720 5.35 937144 0 6523720 0 Y N Vanguard Capital Management, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.No one other person's interest in the securities reported herein is more than 5%. Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Vanguard Capital Management Ashley Grim 04/27/2026